One possible explanation for these varying results is the unique pattern of HER2 expression in each tumor type, as the HER2 protein often demonstrates a more heterogeneous expression pattern in gastric cancers than in breast cancers [50]. This evidence concerns the gene ERBB2 and gastric cancer.